May 1, 2026 8:30 am EDT Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 7, 2026 8:30 am EDT Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors
Apr 6, 2026 8:30 am EDT Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 2, 2026 8:30 am EDT Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York
Mar 17, 2026 7:30 am EDT Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates
Mar 9, 2026 7:30 am EDT Abeona Therapeutics® Provides Business Update Highlighting Building Momentum in ZEVASKYN® Commercial Launch
Mar 3, 2026 7:30 am EST Abeona Therapeutics® Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference
Feb 9, 2026 10:04 am EST Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dec 31, 2025 7:30 am EST Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
